BioNTech aims for 2 billion COVID-19 vaccine doses in 2021
BERLIN, Jan 11 (Reuters) - German COVID-19 vaccine maker BioNTech (22UAy.DE), partner of U.S. pharmaceutical group Pfizer (PFE.N), said on Monday it aims to produce two billion doses of its vaccine this year.
"We now believe that we can potentially deliver approximately 2 billion doses in total by the end of 2021, which incorporates the updated 6-dose label," BioNTech said in a presentation.
Reporting by Thomas Seythal Editing by Riham Alkousaa
Our Standards: The Thomson Reuters Trust Principles.